Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02973750 · ClinicalTrials.gov registry record

Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer

A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Completed
Registry status
20
Enrollment target

NCT02973750: Completed study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

NCT02973750 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02973750 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

While significant progress has been made in the treatment and prognosis of ovarian cancer, this progress has mostly shown benefits for younger women. This study aims to understand two things: How body composition (the amount of muscle and water versus fat in in the body) affects the dose and side effects of chemotherapy; and the biological reason for the worse prognosis with aging. To get a good view of these effects, investigators are asking the help of both younger and older women for this project.

Primary Outcome

Assess the correlation of skeletal muscle index and fat index with the AUC of carboplatin and paclitaxel. Pearson's correlation tests will be performed to assess the correlation of skeletal muscle index and fat index with the AUC of carboplatin and paclitaxel.

Interventions

  • PROCEDURE Tissue Collection
  • PROCEDURE Blood Draws
  • PROCEDURE Baseline Biopsy

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2016-10-20
Est. Completion 2020-07-18

What the finished NCT02973750 record still lists

NCT02973750 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.

The record links to 0 conditions, and to 3 interventions - of which Tissue Collection is the first listed.

NCT02973750 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02973750 about?

NCT02973750 is a clinical study titled "Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer". While significant progress has been made in the treatment and prognosis of ovarian cancer, this progress has mostly shown benefits for younger women. This study aims to understand two things: How body composition (the amount of muscle and water versus fat in in the body) affects the dose and side e...

What is the current status of trial NCT02973750?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2016-10-20. Estimated completion is 2020-07-18.

What interventions are being tested in trial NCT02973750?

The interventions under investigation include: Tissue Collection (PROCEDURE), Blood Draws (PROCEDURE), Baseline Biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT02973750?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02973750, the US trial registry maintained by the National Library of Medicine. NCT02973750 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.